XML 21 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Jun. 30, 2013
CURRENT ASSETS:    
Cash and cash equivalents $ 4,626 $ 9,007
Short term bank deposits 23,345 31,449
Restricted cash and restricted short term deposits 456 316
Marketable securities 28,776 13,441
Other current assets 1,198 872
Total current assets 58,401 55,085
LONG-TERM ASSETS:    
Long-term deposits and restricted deposits 317 421
Severance pay fund 1,135 905
Property and equipment, net 11,449 11,866
Other long term assets 26 39
Total long-term assets 12,927 13,231
Total assets 71,328 68,316
CURRENT LIABILITIES    
Trade payables 2,711 2,837
Accrued expenses 902 1,040
Deferred revenues 379 379
Advance payment from United Therapeutics 297 393
Other accounts payable 1,290 1,272
Total current liabilities 5,579 5,921
LONG-TERM LIABILITIES    
Deferred revenues 3,036 3,226
Accrued severance pay 1,246 1,023
Other long-term liabilities 633 680
Total long-term liabilities 4,915 4,929
COMMITMENTS AND CONTINGENCIES      
STOCKHOLDERS' EQUITY    
Common stock $0.00001 par value: Authorized: 100,000,000 shares Issued and outstanding: 64,392,523 shares as of December 31, 2013, 59,196,617 shares as of June 30, 2013    [1]    [1]
Additional paid-in capital 158,038 144,109
Accumulated deficit (98,362) (86,902)
Other comprehensive income 1,158 259
Total stockholders' equity 60,834 57,466
Total liabilities and stockholders' equity $ 71,328 $ 68,316
[1] Less than $1.